$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
The accumulation of misfolded proteins into insoluble deposits occurs in a wide range of diseases. Well-known examples are the aggregation of amyloid-β and tau in Alzheimer's disease, α-synuclein in Parkinson's disease, and huntingtin with expanded polyQ in Huntington's disease1,2. The misfolding of these polypeptides into amyloid fibrils is associated with toxicity and cell death by mechanisms that are still largely unclear. Elucidating the mechanisms of amyloid formation will be crucial to developing effective therapies, which are currently unavailable.
Detailed investigations of amyloid formation have been performed in vitro based on thioflavin T fluorescence measurements, leading to a mechanistic understanding of the aggregation process and the effect of inhibitory molecules3,4,5. However, it is not clear whether the same aggregation mechanisms hold true in the complex environment of living cells and organisms. The nematode worm Caenorhabditis elegans is a suitable model organism to study protein aggregation in vivo. It has a relatively simple anatomy but consists of multiple tissues, including muscle, intestine, and a nervous system. It is genetically well-characterized, and tools for genetic modification are readily available. Furthermore, it has a short generation time of ~3 days and a total lifespan of 2-3 weeks. As such, protein aggregation can be examined across the lifespan of the animal on an experimentally convenient timescale. Finally, the nematode is optically transparent, enabling the tracking of the aggregation of fluorescently labeled proteins in live animals.
These features of C. elegans have been previously exploited to investigate the aggregation of polyQ proteins as a model for Huntington's and other polyQ expansion diseases. Above the pathogenic threshold of 35-40 glutamine residues, the polyQ proteins labeled with yellow fluorescent protein (YFP) can be observed to form insoluble inclusions in the muscle tissue6,7, neurons8, and the intestine9,10. These features have been widely used to screen for genes11,12,13 and small-molecule modifiers14 of protein aggregation and toxicity.
C. elegans has the potential to play an important role in bridging the gap between in vitro studies of protein aggregation and more complex disease models such as mice15. C. elegans is amenable to drug screening16 but can also be exploited to obtain a fundamental understanding of the molecular mechanisms of protein aggregation in vivo, as demonstrated recently17. However, for both applications, it is of prime importance to extract a quantitative and reproducible measure of protein aggregation. Here, this is achieved with the use of a high-throughput confocal microscope combined with a dedicated image analysis pipeline (Figure 1).